| Date Filed | Type | Description |
| 01/30/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2012 |
SC 13G/A
| MELA SCIENCES, INC. reports a 0% stake in MELA Sciences, Inc. |
| 01/30/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/14/2011 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.4% stake in Boise Inc. |
| 01/13/2011 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.3% stake in Soligenix, Inc. |
| 01/12/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/11/2011 |
SC 13G
| MELA SCIENCES, INC. reports a 6% stake in MELA Sciences, Inc. |
| 01/07/2011 |
SC 13G/A
| MEDIVATION, INC. reports a 0.3% stake in Medivation, Inc. |
| 01/06/2011 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 4.1% stake in Prana Biotechnology Limited |
| 10/13/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/27/2010 |
SC 13G
| MELA SCIENCES, INC. reports a 5.1% stake in MELA Sciences, Inc. |
| 09/07/2010 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 5.4% stake in Boise Inc. |
| 08/20/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 06/03/2010 |
D
| Form D - Notice of Exempt Offering of Securities |
| 05/19/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.9% stake in Medivation, Inc. |
| 05/19/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/18/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 6.2% stake in Prana Biotechnology Limited |
| 05/18/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 7.4% stake in Soligenix, Inc. |
| 03/04/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.9% stake in Prana Biotechnology Limited |
| 02/19/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/19/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 10.3% stake in Prana Biotechnology Limited |
| 01/26/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/25/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9% stake in Medivation, Inc. |
| 01/19/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 0.1% stake in Vanda Pharmaceuticals Inc. |
| 01/13/2010 |
SC 13G/A
| GENTA INC DE reports a 3.2% stake in Genta Incorporated |
| 01/13/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/12/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 5.3% stake in Soligenix, Inc. |
| 01/11/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/11/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 3.1% stake in Emisphere Technologies, Inc. |
| 01/08/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 5% stake in Oculus Innovative Sciences, Inc. |
| 01/08/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 5% stake in Genvec, Inc. |
| 01/07/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/07/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|